Showing results (51-60 of 300) with videos related to
Sort By:
Pageof 30
Anticancer Research|June 29, 2007
Predicting the outcome of squamous cell carcinoma of the uterine cervix using combinations of individual tumor marker expressionsAnnika K Lindström, Ulf Stendahl, Tibor Tot, et al.European Radiology|August 5, 2003
Invasive breast cancer: correlation of dynamic MR features with prognostic factorsBotond K Szabó, Peter Aspelin, Maria Kristoffersen Wiberg, et al.Histopathology|August 17, 2018
Equivocal (HER2 IHC 2+) breast carcinomas: gene-protein assay testing reveals association between genetic heterogeneity, individual cell amplification status and potential treatment benefitsGyula Pekar, Ionna Kasselaki, Agnes Pekar-Lukacs, et al.Anticancer Research|July 15, 2009
Discrepancies in expression and prognostic value of tumor markers in adenocarcinoma and squamous cell carcinoma in cervical cancerAnnika K Lindström, Tibor Tot, Ulf Stendahl, et al.Acta Oncologica (Stockholm, Sweden)|June 18, 2010
LRIG2 in contrast to LRIG1 predicts poor survival in early-stage squamous cell carcinoma of the uterine cervixHåkan Hedman, Annika K Lindström, Tibor Tot, et al.International Journal of Breast Cancer|March 14, 2017
Ductal Breast Carcinoma In Situ: Mammographic Features and Its Relation to Prognosis and Tumour Biology in a Population Based CohortWenjing Zhou, Thomas Sollie, Tibor Tot, et al.Bosnian Journal of Basic Medical Sciences|April 9, 2019
Internodal HER2 heterogeneity of axillary lymph node metastases in breast cancer patientsIlija Vladimir Baroš, Nataša Tanasković, Ulrika Pellas, et al.International Journal of Pharmaceutics|April 25, 2003
Note on the measurement of flowability according to the European PharmacopoeiaAndrea Schüssele, Annette Bauer-BrandlExpert Opinion on Drug Delivery|November 22, 2011
Quality by design (QbD) approaches for the compression step of tabletingIngunn Tho, Annette Bauer-BrandlEuropean Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 4, 2018
Oromucosal drug delivery: Trends in in-vitro biopharmaceutical assessment of new chemical entities and formulationsMartin Brandl, Annette Bauer-BrandlPageof 30